NOVARTIS AG-SPONSORED ADR (NVS) Forecast, Price Target & Analyst Ratings

NYSE:NVSUS66987V1098

Current stock price

154.94 USD
+1.5 (+0.98%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NOVARTIS AG-SPONSORED ADR (NVS).

Forecast Snapshot

Consensus Price Target

Price Target
$156.00
+ 0.68% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 27, 2026
Period
Q1 / 2026
EPS Estimate
$2.16
Revenue Estimate
13.825B

ChartMill Buy Consensus

Rating
70.59%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$156.00
Upside
+ 0.68%
From current price of $154.94 to mean target of $156.00, Based on 34 analyst forecasts
Low
$115.68
Median
$156.86
High
$243.23

Price Target Revisions

1 Month
4.11%
3 Months
15.52%

Price Target Summary

34 Wall Street analysts provided a forecast for the next 12 months for NVS. The average price target is 156 USD. This implies a price increase of 0.68% is expected in the next year compared to the current price of 154.94.
The average price target has been revised upward by 15.52% in the past 3 months.

Analyst Ratings & History

Current Analyst Ratings

NVS Current Analyst RatingNVS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10

Analyst Ratings History

NVS Historical Analyst RatingsNVS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 10 20 30

Analyst Ratings Consensus

ChartMill Buy Consensus
70.59%
NVS was analyzed by 34 analysts. The buy percentage consensus is at 71. So analysts seem to be have mildly positive about NVS.
In the previous month the buy percentage consensus was at a similar level.
NVS was analyzed by 34 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-01-06BarclaysUpgrade Underweight -> Equal-Weight
2025-12-08JP MorganUpgrade Neutral -> Overweight
2025-09-12Goldman SachsDowngrade Neutral -> Sell
2025-02-13UBSDowngrade Buy -> Neutral
2024-11-19Erste GroupDowngrade Buy -> Hold
2024-10-30BMO CapitalMaintains Market Perform -> Market Perform
2024-09-11B of A SecuritiesDowngrade Buy -> Neutral
2024-09-05Goldman SachsDowngrade Buy -> Neutral
2024-09-03JefferiesDowngrade Buy -> Hold
2024-07-02JefferiesMaintains Buy -> Buy
2024-04-24BMO CapitalMaintains Market Perform -> Market Perform
2024-02-23BMO CapitalInitiate Market Perform
2024-01-23Morgan StanleyInitiate Equal-Weight
2023-09-25Morgan StanleyUpgrade Underweight -> Equal-Weight
2022-05-09Wolfe ResearchDowngrade Outperform -> Peer Perform
2021-12-06Exane BNP ParibasDowngrade Outperform -> Neutral
2021-12-03Bryan GarnierDowngrade Buy -> Neutral
2021-09-20Deutsche BankDowngrade Hold -> Sell

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 27, 2026
Period
Q1 / 2026
EPS Estimate
$2.16
Revenue Estimate
13.825B
Revenue Q2Q
4.47%
EPS Q2Q
-5.65%
Number of Analysts
6

Next Earnings Revisions

Revenue (1 Month)
0.03%
Revenue (3 Months)
-3.10%
EPS (1 Month)
-1.72%
EPS (3 Months)
-8.29%

Next Earnings Summary

NVS is expected to report earnings on 4/27/2026. The consensus EPS estimate for the next earnings is 2.16 USD and the consensus revenue estimate is 13.82B USD.
The next earnings revenue estimate has been revised downward by 3.1% in the past 3 months.

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
NVS revenue by date.NVS revenue by date.
46.66B
7.57%
51.722B
10.85%
56.33B
8.91%
58.125B
3.19%
60.978B
4.91%
64.487B
5.75%
69.701B
8.09%
72.171B
3.54%
70.192B
-2.74%
67.191B
-4.28%
64.861B
-3.47%
EBITDA
YoY % growth
NVS ebitda by date.NVS ebitda by date.
20.919B
20.31%
20.919B24.017B
14.81%
23.786B
-0.96%
25.378B
6.69%
27.583B
8.69%
30.438B
10.35%
32.201B
5.79%
29.356B
-8.84%
27.435B
-6.54%
26.31B
-4.10%
EBIT
YoY % growth
NVS ebit by date.NVS ebit by date.
12.642B
23.87%
16.32B
29.09%
18.692B
14.53%
21.034B
12.53%
22.513B
7.03%
24.354B
8.18%
28.023B
15.07%
29.22B
4.27%
29.497B
0.95%
25.596B
-13.23%
24.334B
-4.93%
Operating Margin
NVS operating margin by date.NVS operating margin by date.
27.09%31.55%33.18%36.19%36.92%37.77%40.20%40.49%42.02%38.09%37.52%
EPS
YoY % growth
NVS eps by date.NVS eps by date.
6.94
12.75%
7.85
13.19%
9.03
14.98%
9.09
0.69%
9.91
9.05%
10.74
8.35%
12.30
14.48%
12.95
5.30%
12.58
-2.83%
11.19
-11.08%
10.70
-4.40%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
2.16
-5.65%
2.31
-5.12%
2.27
0.50%
2.05
0.24%
Revenue
Q2Q % growth
13.825B
4.47%
14.473B
2.98%
14.452B
3.90%
14.414B
8.08%
EBITDA
Q2Q % growth
4.868B
-18.05%
5.254B
-30.55%
5.692B
-31.91%
5.522B
-41.82%
EBIT
Q2Q % growth
5.186B
8.36%
5.413B
5.00%
5.569B
21.46%
5.091B
22.20%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

NVS Yearly Revenue VS EstimatesNVS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B
NVS Yearly EPS VS EstimatesNVS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
5.96%
EPS Next 5 Year
7.48%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
4.46%
Revenue Next 5 Year
4.99%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
9.08%
EBIT Next 5 Year
8.66%

NOVARTIS AG-SPONSORED ADR / NVS Forecast FAQ

What is the average price target for NOVARTIS AG-SPONSORED ADR (NVS) stock?

34 analysts have analysed NVS and the average price target is 156 USD. This implies a price increase of 0.68% is expected in the next year compared to the current price of 154.94.

What is the next earnings date for NVS stock?

NOVARTIS AG-SPONSORED ADR (NVS) will report earnings on 2026-04-27.

What are the consensus estimates for NOVARTIS AG-SPONSORED ADR (NVS) next earnings?

The consensus EPS estimate for the next earnings of NOVARTIS AG-SPONSORED ADR (NVS) is 2.16 USD and the consensus revenue estimate is 13.82B USD.

Can you provide the expected long term growth rate for NOVARTIS AG-SPONSORED ADR stock?

The expected long term growth rate for NOVARTIS AG-SPONSORED ADR (NVS) is 4.46%.